You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-Remission Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Italy (Vidaza 100 milligram (mg) injection, Best Supportive Care)

Completed
  • Acute Myeloid Leukemia
  • Vidaza 100 milligram (mg) injection
  • Best Supportive Care
  • Alessandria, AL, Italy
  • +17 more
Jan 13, 2022

Acromegaly Trial in Santa Monica (lanreotide)

Terminated
Has Results
  • Acromegaly
  • Santa Monica, California
    Brain Tumor Center and Pituitary Disorders Program, John Wayne C
Sep 2, 2021

Acute Myeloid Leukemia Trial in France (Dexamethasone)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Angers, France
  • +24 more
Jul 26, 2022

Support and Post-therapeutic Rehabilitation for Complete

Not yet recruiting
  • Non-Metastatic Breast Carcinoma
  • +2 more
    • (no location specified)
    Jul 4, 2022

    Rectal Cancer Trial in Taipei (Surgery)

    Recruiting
    • Rectal Cancer
    • Surgery
    • Taipei, Taiwan
      Jin-Tung LIANG
    Jul 27, 2023

    Heart Failure, Cardiomyopathy, Dilated, Cardiomyopathies Trial (Other)

    Not yet recruiting
    • Heart Failure
    • +3 more
    • (no location specified)
    Oct 17, 2023

    Neuroblastoma Trial (horse therapy)

    Not yet recruiting
    • Neuroblastoma
    • horse therapy
    • (no location specified)
    Feb 22, 2023

    Acute Myeloid Leukemia Trial in Oslo (WT1/PRAME vaccination)

    Completed
    • Acute Myeloid Leukemia
    • WT1/PRAME vaccination
    • Oslo, Norway
      Oslo University Hospital, Rikshospitalet
    Jul 6, 2020

    Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

    Recruiting
    • Giant Cell Arteritis
    • Bonn, Germany
      Medical Clinic and Polyclinic III Internal medicine Oncology, He
    Dec 16, 2022

    Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)

    Not yet recruiting
    • Secondary Acute Myeloid Leukemia
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Mar 22, 2023

    Severe Alcoholic Hepatitis Trial in New Delhi (Prednisolone, Standard Medical therapy, Placebo)

    Not yet recruiting
    • Severe Alcoholic Hepatitis
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences (ILBS)
    Dec 2, 2023

    Stress Disorders, Post-Traumatic Trial in Pittsburgh (Apollo Wearable)

    Recruiting
    • Stress Disorders, Post-Traumatic
    • Apollo Wearable
    • Pittsburgh, Pennsylvania
      Apollo Neuroscience, Inc.
    Jan 31, 2023

    Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

    Recruiting
    • Acute Myeloid Leukemia
    • Venclexta 100 MG Oral Tablet
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Jun 11, 2023

    Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • Methylprednisolone Injectable Suspension
    • +2 more
    • Nanjing, Jiangsu, China
      Jiong Zhang
    May 8, 2023

    Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)

    Not yet recruiting
    • Diffuse Large B-cell Lymphoma (DLBCL)
    • Lanzhou, Gansu, China
      The First Hospital of Lanzhou University
    Oct 23, 2022

    ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)

    Recruiting
    • ANCA-associated Vasculitis
    • Maintenance Therapy
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 20, 2023

    Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

    Not yet recruiting
    • Diffuse Large B-cell Lymphoma
    • Mitoxantrone hydrochloride liposome injection
    • +4 more
    • Changchun, Jilin, China
      The First Bethune Hospital of Jilin University
    Aug 15, 2023

    Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

    Recruiting
    • Acute Myeloid Leukemia in Remission
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2022

    Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)

    Recruiting
    • Acute Myeloid Leukemia (AML) in Remission
    • Suzhou, Jiangsu, China
    • +1 more
    Aug 18, 2022

    Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
    • +2 more
    • Riyadh, Saudi Arabia
      King Faisal Specialist Hospital & Research Center
    Apr 4, 2022

    PTSD (PTSD) Trial in Fort Hood, San Antonio, Waco (Massed Prolonged Exposure, Intensive Outpatient Prolonged Exposure)

    Completed
    • Posttraumatic Stress Disorder (PTSD)
    • Massed Prolonged Exposure
    • Intensive Outpatient Prolonged Exposure
    • Fort Hood, Texas
    • +3 more
    Aug 5, 2022

    Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 25, 2022

    Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Oral azacitidine
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    HIV/AIDS Trial in San Francisco (Combination Intervention)

    Active, not recruiting
    • HIV/AIDS
    • Combination Intervention
    • San Francisco, California
      Zuckerberg San Francisco General Hospital, University of Califor
    Mar 21, 2022

    Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Stem Cell Transplantation
    • Tel Aviv, Israel
    • +2 more
    Jan 23, 2023